Startup India Government of India
Claroid Pharmaceuticals Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹98.31 Cr
▲ 48% YoY
Net profit · FY 2025
₹11.19 Cr
Net margin 11.4%
EBITDA · FY 2025
₹18.61 Cr
EBITDA margin 18.9%
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹15 Cr
Issued & subscribed
Open charges
₹33.83 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Employees · EPFO
31
Provident fund records
About Claroid Pharmaceuticals Limited
Data last updated:
Claroid Pharmaceuticals Limited is a public limited company based in Ahmedabad, Gujarat, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24304GJ2018PLC103796. Its GSTIN is 24AAHCC7216Q1ZA (Gujarat).
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹15 Cr. It is led by directors including Rushin Baijubhai Desai (Whole-Time Director) and Snehalkumar Hasmukhlal Soni (Whole-Time Director).
Its last annual general meeting (AGM) was held on 31 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹98.31 Cr, a growth of 48% compared to the previous year. For the same year it recorded a net profit of ₹11.19 Cr (net margin 11.4%) and EBITDA of ₹18.61 Cr (EBITDA margin 18.9%). Revenue has grown at a compounded annual rate (CAGR) of 55% over three years.
The company has about 31 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Claroid Pharmaceuticals. As per MCA filings, the company has open charges of ₹33.83 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
Claroid Pharmaceuticals Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0043717). For more details, the company can be reached via its website claroidpharma.com.
Company Details of Claroid Pharmaceuticals Limited
CIN U24304GJ2018PLC103796
Registration Number 103796
Incorporation Date 31 August 2018
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 July 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Medium
Udyam Registration UDYAM-GJ-01-0043717
CIN History of Claroid Pharmaceuticals Limited
Claroid Pharmaceuticals has one previous CIN (Corporate Identification Number): U24304GJ2018PTC103796. The current CIN is U24304GJ2018PLC103796, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24304GJ2018PLC103796 | Current |
| U24304GJ2018PTC103796 | Previous |
Key People
Rushin Baijubhai Desai Whole-Time Director Snehalkumar Hasmukhlal Soni Whole-Time Director Shailesh Arjanbhai Patel Whole-Time Director Recognitions & Rankings of Claroid Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-GJ-01-0043717
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressS.No – 217/P Opp Gurukul English School, Kamod – Pirana Road, Ahmedabad, Gujarat, India – 382425
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Claroid Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Claroid Pharmaceuticals Limited
Claroid Pharmaceuticals operates one associated brand: Claroid Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and innovative medicine development in India. | claroidpharma.com |
Business Activity of Claroid Pharmaceuticals Limited
The main business activity of Claroid Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Claroid Pharmaceuticals Limited FY 2025 filings available
Claroid Pharmaceuticals Limited reported revenue of ₹98.31 Cr (up 48% YoY) for FY 2025.
Revenue · FY 2025
₹98.31 Cr ▲ 48%
Net profit · FY 2025
₹11.19 Cr margin 11.4%
EBITDA · FY 2025
₹18.61 Cr margin 18.9%
Compounded Annual Growth Rate (CAGR) of Claroid Pharmaceuticals Limited
Revenue CAGR growth
1 year
▲ 48%
3 years · compounded
▲ 55%
EBITDA CAGR growth
1 year
▲ 55%
3 years · compounded
▲ 82%
Revenue has grown at a compounded annual rate (CAGR) of 55% over three years, including 48% growth in the latest year. EBITDA rose 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Claroid Pharmaceuticals Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹18.61 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹11.19 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Claroid Pharmaceuticals Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 11.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Claroid Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors and KMP of Claroid Pharmaceuticals Limited
Claroid Pharmaceuticals Limited currently reports 7 directors and 1 key managerial person. 9 former directors have served the organization.
Current Directors and KMP
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rushin Baijubhai Desai | Whole-Time Director | 31 Aug 2018 | 8 Years 1 Months | Current |
| Arpankumar Patel | Director | 28 Apr 2025 | 1 Years 5 Months | Current |
| Ghanshyam Arjanbhai Patel Also directs: Accent Microcell Limited, Accent Biosciences Private Limited | Director | 31 Aug 2018 | 8 Years 1 Months | Current |
| Snehalkumar Hasmukhlal Soni Also directs: Brohks Healthcare Private Limited | Whole-Time Director | 31 Aug 2018 | 8 Years 1 Months | Current |
| Shailesh Arjanbhai Patel | Whole-Time Director | 31 Aug 2018 | 8 Years 1 Months | Current |
| Shashwat Yatishkumar Shah Also directs: Indo SMC Limited | Director | 28 Apr 2025 | 1 Years 5 Months | Current |
Showing 6 of 8 current directors and KMP. View all directors and KMP
Peer Comparison of Claroid Pharmaceuticals Limited
Claroid Pharmaceuticals Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Addii Biotech Private Limited | ₹100.32 Cr (FY 2025) | •••• | •••• | 59.0% | •••• | Chandigarh, India |
| Medibios Laboratories Limited | ₹100.12 Cr (FY 2023) | •••• | •••• | -2.0% | •••• | |
| Angel Biogenics Private Limited | ₹99.49 Cr (FY 2025) | •••• | •••• | -22.0% | •••• | Rajkot, Gujarat, India |
| Synokem Lifesciences Private Limited | ₹99.46 Cr (FY 2025) | •••• | •••• | 108.0% | •••• | New Delhi, Delhi, India |
| Shri Nivas (Gujarat) Laboratories Pvt Ltd | ₹98.85 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Patna, Bihar, India |
| Claroid Pharmaceuticals Limited this company | ₹98.31 Cr (FY 2025) | •••• | •••• | 48.0% | •••• | Ahmedabad, Gujarat, India |
| Sirmour Remedies Private Limited | ₹98.1 Cr (FY 2025) | •••• | •••• | -18.0% | •••• | Paonta Sahib, Himachal Pradesh, India |
| Visa Pharmaceuticals Private Limited | ₹98.08 Cr (FY 2016) | •••• | •••• | 34.0% | •••• | Kolkata, West Bengal, India |
| Enicar Pharmaceuticals Private Limited | ₹97.81 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Boisar, Maharashtra, India |
| Astonea Labs Limited | ₹97.71 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Chandigarh, India |
| Veer Chemie and Aromatics Pvt Ltd | ₹97.47 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Telangana, India |
Peers are the five companies nearest above and the five nearest below Claroid Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Claroid Pharmaceuticals Limited
Claroid Pharmaceuticals Limited is audited by RAJIV SHAH & ASSOCIATES for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAJIV SHAH & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Claroid Pharmaceuticals Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Claroid Pharmaceuticals Limited
Open charges
₹33.83 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Feb 2020 | Hdfc Bank Limited | ₹33.83 Cr | Open |
Total charge records: 1 View all charges
Legal Cases of Claroid Pharmaceuticals Limited
Claroid Pharmaceuticals Limited has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 30 Sep 2026.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Court case (AGRMNT-LC) | Filed against the company by an individual | Disposed |
Premium access
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Claroid Pharmaceuticals Limited
Claroid Pharmaceuticals Limited has a workforce of 31 employees as of Mar 29, 2025.
Employee count
31
Active EPFO establishments
1
Employee growth
63.16%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Claroid Pharmaceuticals Limited
Claroid Pharmaceuticals Limited has 17 board changes on record since 2018: 8 appointments and 9 cessations. The latest: Arpankumar Patel ceased to be Additional Director on 30 Jul 2025.
AGM
Claroid Pharmaceuticals Limited last Annual general meeting of members was held on 31 Jul 2025 as per latest MCA records.
Ceased
Arpankumar Patel ceased to be Additional Director.
Ceased
Chandrika Joshi ceased to be Additional Director.
Ceased
Shashwat Yatishkumar Shah ceased to be Additional Director.
Appointed
Baiju Bhupendrabhai Desai was appointed as CFO.
Ceased
Baiju Bhupendrabhai Desai ceased to be Director.
Ceased
Ghanshyam Arjanbhai Patel ceased to be Director.
Ceased
Rushin Baijubhai Desai ceased to be Director.
Ceased
Shailesh Arjanbhai Patel ceased to be Director.
Ceased
Snehalkumar Hasmukhlal Soni ceased to be Director.
Appointed
Arpankumar Patel was appointed as Director.
Appointed
Chandrika Joshi was appointed as Director.
10 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Claroid Pharmaceuticals Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Claroid Pharmaceuticals Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Claroid Pharmaceuticals Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Claroid Pharmaceuticals Limited
Claroid Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAHCC7216Q1ZA | Gujarat | Active | 04 Dec 2018 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Claroid Pharmaceuticals Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Claroid Pharmaceuticals Limited
Claroid Pharmaceuticals is an active public limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 August 2018 (8+ years old) and is registered under CIN U24304GJ2018PLC103796.
Claroid Pharmaceuticals reported revenue of ₹98.31 Cr for FY 2025 (up 48% YoY).
Claroid Pharmaceuticals has 8 current directors and KMP:
- Rushin Baijubhai Desai - Whole-Time Director
- Snehalkumar Hasmukhlal Soni - Whole-Time Director
- Shailesh Arjanbhai Patel - Whole-Time Director
- Arpankumar Patel - Director
- Ghanshyam Arjanbhai Patel - Director
- Shashwat Yatishkumar Shah - Director
- Chandrika Joshi - Director
- Baiju Bhupendrabhai Desai - Cfo
Claroid Pharmaceuticals reported a net profit of ₹11.19 Cr (net margin 11.4%) and EBITDA of ₹18.61 Cr (EBITDA margin 18.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Claroid Pharmaceuticals is 55% over three years. In the latest year (FY 2025) revenue rose 48%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Claroid Pharmaceuticals is 24AAHCC7216Q1ZA, registered in Gujarat.
The CIN (Corporate Identification Number) of Claroid Pharmaceuticals is U24304GJ2018PLC103796. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Claroid Pharmaceuticals has 1 court case on record: 1 filed against it.
Claroid Pharmaceuticals was incorporated on 31 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Claroid Pharmaceuticals by revenue are Addii Biotech Private Limited, Medibios Laboratories Limited, Angel Biogenics Private Limited, Synokem Lifesciences Private Limited, Shri Nivas (Gujarat) Laboratories Pvt Ltd and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Arpankumar Patel ceased to be Additional Director on 30 Jul 2025. Chandrika Joshi ceased to be Additional Director on 30 Jul 2025. Shashwat Yatishkumar Shah ceased to be Additional Director on 30 Jul 2025. Claroid Pharmaceuticals has 17 board changes on record in total.